Acceder

Publicaciones - CARDIOLOGIA CLINICA Y EXPERIMENTAL

Cargando...
Bayonas-Ruiz A, Munoz-Franco FM, Sabater-Molina M, Martinez-Gonzalez-Moro I, Gimeno-Blanes JR, Bonacasa B. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study. J Clin Med. 2024 Apr 17;13(8):2324. doi: 10.3390/jcm13082324. PubMed PMID: 38673596; PubMed Central PMCID: PMC11050913.
AÑO: 2024; IF: 2.9
38673596
Garcia-Pavia P, Palomares JFR, Sinagra G, Barriales-Villa R, Lakdawala NK, Gottlieb RL, Goldberg RI, Elliott P, Lee P, Li H, Angeli FS, Judge DP, MacRae CA; REALM-DCM Investigators. REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic LMNA-Related Dilated Cardiomyopathy. Circ Heart Fail. 2024 Jul;17(7):e011548. doi: 10.1161/CIRCHEARTFAILURE.123.011548. Epub 2024 Jul 9. PubMed PMID: 38979608; PubMed Central PMCID: PMC11244753.
AÑO: 2024; IF: 8.4
38979608
Pastor-Pérez F.J., Garrido-Bravo I.P., Peñafiel-Verdú P., Fernández-Villa N., Manzano-Fernández S., Oliva-Sandoval M.J., Pérez-Martínez M.T., Caro-Martínez C., Hernández-Vicente Á., Pascual-Figal D.A. Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial. Revista Espanola de Cardiologia. October 2024. 77:851-858. 10.1016/j.recesp.2024.02.020
AÑO: 2024; IF: 7.2
38701881
Pastor-Pérez F.J., Veas-Porlán M., Fernández-Villa N., Garrido-Bravo I.P., Manzano-Fernández S., Pascual-Figal D.A. Semi-quantitative pulmonary congestion score: prevalence and diuretic management implications after heart failure discharge. Revista Clinica Espanola. March 2024. 224:157-161. 10.1016/j.rce.2023.11.013
AÑO: 2024; IF: 1.7
38355098
Bayonas-Ruiz A., Muñoz-Franco F.M., Sabater-Molina M., Martínez-González-Moro I., Gimeno-Blanes J.R., Bonacasa B. Concurrent Resistance and Cardiorespiratory Training in Patients with Hypertrophic Cardiomyopathy: A Pilot Study. Journal of Clinical Medicine. April 2024. 13. 10.3390/jcm13082324
AÑO: 2024; IF: 2.9
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

CARDIOLOGIA CLINICA Y EXPERIMENTAL